Cerberus Research LabsAmerican-run from Asia / US combat veteran owned and operated
Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide. It is studied in metabolic, incretin-signaling, and glucose-regulation research models, and is supplied strictly as a research-use-only catalog material for qualified laboratory workflows.
Research Use Only. No clinical, diagnostic, human, or veterinary use.
Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide. It is studied in metabolic, incretin-signaling, and glucose-regulation research models, and is supplied strictly as a research-use-only catalog material for qualified laboratory workflows. Any discussion of future applications is hypothetical and should not be interpreted as human or veterinary use guidance.
Research discussion focuses on pathway signaling and assay behavior in controlled laboratory models, not human outcomes or dosing.
Current literature and supplier documentation are reviewed in the context of compound identity, lot consistency, assay suitability, and controlled research workflow design.
Any future application discussion is hypothetical, non-promotional, and not clinical guidance. This listing is restricted to laboratory research-use-only review.
Reference placeholders can be added after legal and scientific review. Do not treat this catalog page as medical or regulatory advice.
Identity and composition data for this compound. Lot-specific purity is reported on the certificate of analysis for the lot supplied — see the Documentation Status section.
Our free peptide reconstitution calculator converts vial mass and BAC water volume into concentration, volume per draw, and U-100 syringe units. It is arithmetic for laboratory preparation only — it is not dosing guidance, and it says nothing about how Tirzepatide should be used.
The certificate of analysis for the lot supplied is published below — you do not have to ask for it. Open COA image
Research-use-only supply questions. Nothing here is dosing, protocol, or usage guidance.
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied in metabolic research models for its combined incretin receptor activity. Cerberus supplies it as a research-use-only catalog material for laboratory study.
Yes. Every Tirzepatide lot is supplied with certificate-of-analysis documentation available on request, and the COA image for the current lot is linked in the Documentation Status section on this page. Lot documentation can be requested before an order is placed.
Tirzepatide ships to the United States and 20+ countries including Canada, the United Kingdom, Australia, Ireland, the Philippines, and South Africa. Checkout is processed in USD through Stripe; some destinations may be unavailable because of carrier suspension or local import restrictions.
Orders are packed discreetly with secure protective packaging for laboratory transport. Tracking is provided once the order ships, and shipping questions are answered directly by U.S. veteran-run support.
Yes. Tirzepatide is supplied strictly as a research-use-only catalog material. It is not for human or veterinary use, and not for clinical or diagnostic application. Purchasers confirm research-use-only intent at checkout.
RUO
Semaglutide is being researched for its role in GLP-1 signaling, metabolic regulation, appetite-signaling models, and glucose-related research pathways.
RUO
Retatrutide is being researched for its role in GLP-1, GIP, and glucagon signaling pathways within metabolic and body-composition research models.
RUO
Cagrilintide is being researched within metabolic research, appetite signaling, glucose regulation as a research-use-only catalog material for qualified laboratory and analytical workflows.
